Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting

Area of Science:

• Oncology
• Nanomedicine
• Pharmacology

Background:

• Conventional chemotherapy faces challenges in tumor selectivity, leading to significant side effects.
• Tumor vasculature exhibits unique properties like hypervascularization and leaky vessels, offering a target for drug delivery.

Purpose of the Study:

• To explore the potential of nano-sized anticancer drugs utilizing the enhanced permeability and retention (EPR) effect for selective tumor targeting.
• To highlight the advantages of nanotherapy in improving therapeutic outcomes and minimizing toxicity in cancer treatment.

Main Methods:

• Administration of nano-sized macromolecular anticancer drugs intravenously.
• Exploitation of abnormal tumor vasculature and lack of lymphatic drainage for drug accumulation.
• Monitoring of drug concentration in plasma and tumor tissues over time.

Main Results:

• Nano-sized drugs exhibit prolonged plasma half-life due to hindered renal clearance.
• Selective extravasation of nanoparticles into tumor tissues is facilitated by aberrant tumor vasculature.
• Significant accumulation of nano-drugs in tumors, several-fold higher than plasma concentration, due to impaired lymphatic drainage.

Conclusions:

• The EPR effect provides an effective strategy for selective anticancer nanotherapy.
• High local concentrations of nano-sized drugs in tumors lead to superior therapeutic effects with reduced side effects.
• Nanomedicine holds significant promise for advancing cancer treatment paradigms.